Skip to main content
null
prnano
  • Menu
  • Articles
    • Case study
    • Communication
    • Editorial
    • Editorial Policies
    • Expression of concern
    • Letters to the Editor
    • Perspective, Opinion, or Discussion
    • Research Article
    • Review
    • Technical Note
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • Blog
  • The Rising Talents List
  • Journal Policies
  • search
  • Facebook (opens in a new tab)
  • LinkedIn (opens in a new tab)
  • RSS feed (opens a modal with a link to feed)

RSS Feed

Enter the URL below into your favorite RSS reader.

http://localhost:16084/feed
ISSN 2639-9431
Perspective, Opinion, or Discussion
Vol. 7, Issue 1, 2024January 08, 2024 EDT

Effectiveness of Lecanemab on Alzheimer’s Disease

Flen John Thomas, Mohammad Aamir Qayyum Sarguroh Khan, Ramlah Atif Khan, Sarthak Vasantkumar Patel,
Monoclonal antibodiesAmyloid-βLecanemabEfficacyAlzheimer'sFDA approvedoverview
Copyright Logoccby-nc-4.0 • https://doi.org/10.33218/001c.92098
prnano
Thomas, Flen John, Mohammad Aamir Qayyum Sarguroh Khan, Ramlah Atif Khan, and Sarthak Vasantkumar Patel. 2024. “Effectiveness of Lecanemab on Alzheimer’s Disease.” Precision Nanomedicine 7 (1): 1211–20. https:/​/​doi.org/​10.33218/​001c.92098.

View more stats

This website uses cookies

We use cookies to enhance your experience and support COUNTER Metrics for transparent reporting of readership statistics. Cookie data is not sold to third parties or used for marketing purposes.

cookies
cookies
cookies
Powered by Scholastica, the modern academic journal management system